
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Surg. , 11 May 2022
Sec. Surgical Oncology
Volume 9 - 2022 | https://doi.org/10.3389/fsurg.2022.862617
A retraction of this article was approved in:
Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients
This article has been retracted. Please follow the link to the full retraction notice for details.
Citation: Liu H, Hu X, Wang L, Du T, Feng J, Li M, Liu L and Liu X (2022) Longitude Variation of the microRNA-497/FGF-23 Axis during Treatment and Its Linkage with Neoadjuvant/Adjuvant Trastuzumab-Induced Cardiotoxicity in HER2-Positive Breast Cancer Patients. Front. Surg. 9:862617. doi: 10.3389/fsurg.2022.862617
Received: 26 January 2022; Accepted: 11 April 2022;
Published: 11 May 2022;
Retracted: 11 October 2023.
Edited by:
Einar Kristiansen, Norwegian Radium Hospital, Oslo University Hospital, NorwayReviewed by:
Ruoyu Deng, Fudan University, ChinaSpecialty section: This article was submitted to Surgical Oncology, a section of the journal Frontiers in Surgery
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.